Invesco Bloomberg Analyst Rating Improvers ETF logo

Invesco Bloomberg Analyst Rating Improvers ETF (UPGD)

Market Closed
4 Jun, 20:00
ARCA ARCA
$
82. 36
+0.26
+0.3158%
$
112.76M Market Cap
3.43% Div Yield
514 Volume
$ 82.1
Previous Close
Investors:
Add Transaction
Day Range
82.3 82.36
Year Range
69.16 82.36
Want to track UPGD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

UPGD closed today higher at $82.36, an increase of 0.3158% from yesterday's close, completing a monthly increase of 0.2312% or $0.19. Over the past 12 months, UPGD stock gained 11.1171%.
UPGD pays dividends to its shareholders, with the most recent payment made on Dec 26, 2025. The next estimated payment will be in In 6 months on Dec 26, 2026 for a total of $1.29261.
The stock of the company had never split.
The company's stock is traded on one exchange.

UPGD Chart

UPGD: Sadly Underdelivers, And My Skeptical Stance Is Unchanged

UPGD: Sadly Underdelivers, And My Skeptical Stance Is Unchanged

Invesco Bloomberg Analyst Rating Improvers ETF tracks the Bloomberg ANR Improvers Index that includes 50 analysts' darlings. Despite the alluring strategy, UPGD's performance has been underwhelming, as it has delivered only a single-digit total return this year and trailed IVV since March 2024. Its AUM has been fluctuating around $100 million this year, indicating rather muted investor interest. So UPGD's liquidity is not particularly ample, which is another weakness.

Seekingalpha | 6 months ago
UPGD: Portfolio Of Analysts' Darlings Investors Should Be Realistic About

UPGD: Portfolio Of Analysts' Darlings Investors Should Be Realistic About

Tracking the Bloomberg ANR Improvers Index, UPGD offers exposure to 50 analysts' darlings. This is a high-turnover strategy, and significant quarterly changes in the sector and factor mix should not come as a surprise. At this point, UPGD is heavy in industrials, IT, and consumer staples.

Seekingalpha | 1 year ago
UPGD: For Now, No Meaningful Achievements With The New Strategy

UPGD: For Now, No Meaningful Achievements With The New Strategy

After the strategy change in March 2024, UPGD tracks the Bloomberg ANR Improvers Index. The idea to capitalize on equity research analysts' darlings is appealing, but returns are less so. UPGD has underperformed IVV since the index change, with December being especially challenging, and its contrarian equity mix is to blame.

Seekingalpha | 1 year ago

Invesco Bloomberg Analyst Rating Improvers ETF Investors

Name Quantity Cost Value Profit ($) Gain (%)
MEG
Millstone Evans Group LLC Millstone Evans Group LLC
4,082 $297,438 $336,193.52 $38,755.52 13.03%

Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) FAQ

What is the stock price today?

The current price is $82.36.

On which exchange is it traded?

Invesco Bloomberg Analyst Rating Improvers ETF is listed on ARCA.

What is its stock symbol?

The ticker symbol is UPGD.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.43%.

What is its market cap?

As of today, the market cap is 112.76M.

Has Invesco Bloomberg Analyst Rating Improvers ETF ever had a stock split?

No, there has never been a stock split.

Invesco Bloomberg Analyst Rating Improvers ETF Profile

ARCA Exchange
US Country

Overview

The company is an investment fund that closely aligns its investment strategy with the performance of a specific underlying index. This index is distinctive because it focuses on equity securities that have shown the most significant improvement in Consensus Ratings, according to data from Bloomberg Analyst Recommendations (ANR), an important and reputable data source in the financial world. The index is managed and updated by an index provider, which is closely affiliated with Bloomberg, ensuring that the fund's investment strategy is supported by high-quality and up-to-date financial analyses. By committing at least 90% of its total assets to securities within this carefully selected index, the company aims to provide its investors with a focused and informed investment strategy that taps into the market potential of highly rated equity securities.

Products and Services

  • Equity Securities Investment
  • This service is at the core of the company's offerings, focusing on investing in equity securities that have shown significant improvement in Consensus Ratings. By targeting these high-potential equity securities, the company seeks to leverage the analytical insights provided by Bloomberg ANR to invest confidently in entities expected to outperform in the market. This approach enables investors to potentially achieve higher returns influenced by the professional and consensus-based evaluations of securities' prospects.

  • Index-Based Investment Strategy
  • The company utilizes a robust investment strategy that mirrors the performance of a specifically curated index, which includes equity securities with remarkable improvements in their Bloomberg ANR ratings. This methodical approach allows for a disciplined investment process, focusing on a pre-defined set of criteria for inclusion in the investment portfolio. The underlying index's consistent update and maintenance by the index provider ensure that the investment strategy remains aligned with the latest market trends and analyses, providing a dynamic yet structured investment opportunity.

  • Access to Bloomberg Analyst Recommendations
  • Through its affiliation with the index provider, the company offers investors indirect access to Bloomberg Analyst Recommendations (ANR). This association means that investment decisions are informed by comprehensive and up-to-date financial analyses from one of the leading financial data providers. Bloomberg's ANR provides a consensus rating system, which is an amalgamation of various analyst opinions, offering a more rounded view of the equity securities' potential. This access is pivotal in formulating the underlying index and, by extension, the fund's investment strategy.

Contact Information

Address: 11 Greenway Plaza, Suite 1000
Phone: 1-800-983-0903